about
Blood glucose and risk of incident and fatal cancer in the metabolic syndrome and cancer project (me-can): analysis of six prospective cohortsThe challenge of measuring circulating estradiol at low concentrationsCirculating soluble Fas levels and risk of ovarian cancerReliability of follicle-stimulating hormone measurements in serumFruits and vegetables and lung cancer: Findings from the European Prospective Investigation into Cancer and NutritionHbA1c measured in stored erythrocytes is positively linearly associated with mortality in individuals with diabetes mellitusInsulin-like growth factor-i and risk of differentiated thyroid carcinoma in the European prospective investigation into cancer and nutritionMaternal hormones during early pregnancy: a cross-sectional studyIGF-I during primiparous pregnancy and maternal risk of breast cancerEffect of long-term storage on hormone measurements in samples from pregnant women: the experience of the Finnish Maternity Cohort.Dietary flavonoid and lignan intake and breast cancer risk according to menopause and hormone receptor status in the European Prospective Investigation into Cancer and Nutrition (EPIC) Study.Free β-human chorionic gonadotropin, total human chorionic gonadotropin and maternal risk of breast cancerMeat consumption and colorectal cancer risk: dose-response meta-analysis of epidemiological studies.Human chorionic gonadotropin in pregnancy and maternal risk of breast cancer.Obesity, inflammatory markers, and endometrial cancer risk: a prospective case-control study.Multiple miscarriages are associated with the risk of ovarian cancer: results from the European Prospective Investigation into Cancer and NutritionC-reactive protein and ovarian cancer: a prospective study nested in three cohorts (Sweden, USA, Italy).Reproductive factors and exogenous hormone use in relation to risk of glioma and meningioma in a large European cohort studyLong noncoding RNA TARID directs demethylation and activation of the tumor suppressor TCF21 via GADD45A.Inflammatory and metabolic biomarkers and risk of liver and biliary tract cancer.Circulating sex steroids during pregnancy and maternal risk of non-epithelial ovarian cancerCirculating inflammation markers and risk of epithelial ovarian cancerObesity, endogenous hormones, and endometrial cancer risk: a synthetic review.Reproductive factors and risk of hormone receptor positive and negative breast cancer: a cohort studyAssociation of serum 25-hydroxyvitamin D (25-OHD) concentrations with maternal sex steroids and IGF-1 hormones during pregnancyCirculating insulin-like growth factor-I in pregnancy and maternal risk of breast cancerCirculating estrogens and progesterone during primiparous pregnancies and risk of maternal breast cancer.Determinants of maternal sex steroids during the first half of pregnancyHepatocellular carcinoma risk factors and disease burden in a European cohort: a nested case-control studyFactors associated with inflammation markers, a cross-sectional analysis.Endogenous hormones and ovarian cancer: epidemiology and current hypotheses.Prediagnostic 25-hydroxyvitamin D, VDR and CASR polymorphisms, and survival in patients with colorectal cancer in western European ppulations.Total and high-molecular weight adiponectin and risk of colorectal cancer: the European Prospective Investigation into Cancer and Nutrition Study.Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort studyVitamin D receptor polymorphisms and risk of epithelial ovarian cancer.Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC).Circulating prolactin levels and risk of epithelial ovarian cancer.Premenopausal Circulating Androgens and Risk of Endometrial Cancer: results of a Prospective Study.Height, body mass index, and ovarian cancer: a pooled analysis of 12 cohort studies.Human chorionic gonadotropin and alpha-fetoprotein concentrations in pregnancy and maternal risk of breast cancer: a nested case-control study.
P50
Q21090132-9BA62CF6-847B-4AE0-85AC-373FF9D9ABCBQ24797684-50AACFA0-1A8A-46A7-A036-90CAACD06C86Q24805356-702A49D3-302F-4764-A9A3-5389E6E36C32Q24806264-5D009D47-1B08-4EAA-8029-1BFA738A38D7Q28187509-C2984BE3-E49D-4938-9281-A5A473E72A92Q28728521-AF92B073-25BB-4D3B-B694-D9A7AF1BB7C0Q33716534-C411A968-A283-4BC7-A563-6A1B93EF2BEBQ33893191-4B88E02B-7037-4E3B-B349-4F9694C3403FQ33916778-3C565C3A-BC27-405E-B6D0-E501E0F52B83Q33916791-EB365B26-C298-4668-A450-F67168F919FAQ34036279-1A71BEA1-781E-434E-9F74-223879CAA5DEQ34086249-83939A8B-2871-4BCA-A223-494116C7DF3AQ34115278-FAA4978A-AC7C-4CBF-A78E-0F92C21EFE41Q34235316-B017D3BF-0096-447A-8B36-54188835E816Q34252237-F9D6142C-DF49-4B24-9675-5ABF79E4CAB7Q34279823-CE9BBEA7-5E8E-4F80-9131-0111A9FB97C8Q34304775-C28D74EA-632C-49A1-BC07-062F056D1666Q34342499-B827DDED-B795-46F2-A35E-3B8C79D5999AQ34432092-76377EF9-FC94-4D5E-A6BB-96AA5CCDC316Q34511085-C52402CF-CCB6-402A-A169-99E56E7020F0Q34854745-9A4EDB6F-CBF1-44AB-9EC2-F15A9D49F3CDQ34949061-F3C87C12-B1E9-48E4-9949-913EEC0EC5C7Q35032177-18AFBF57-9A7E-46C8-9240-86DD4DBF4024Q35062955-27A4C918-405B-43B9-82E9-A50DA23B0CDEQ35090243-53354395-4AB7-4E6E-AFDE-D3A4C0FC7289Q35156893-38A57743-A0A6-43C3-A390-88E5FAD8A121Q35291547-35015CFA-F0C0-4EA9-912A-66050A104BB9Q35512365-318FC636-0708-4D81-90FD-E931325DE8B1Q35552074-74B17678-B103-4638-B16D-7830C0E61F5AQ35633792-47E91F91-9A49-427D-8976-E08BA3A6D998Q36019178-847AFC64-9B27-43FA-850C-2D8BA07A4BFCQ36043460-E248289D-8C57-4719-8508-954ABFC73969Q36072581-C1649D8D-D747-4639-B3B6-86B493DAB5F9Q36245367-5DF2B6E2-82EC-4190-8E25-58E7AC904920Q36484743-937C7702-CBA1-439D-815B-B65993283A84Q36676316-EFFACE2C-53B6-4113-B124-DE28CF910611Q36698788-92AEE32C-8813-4578-8935-738AC50422FFQ36880019-729B8FA3-A8B9-408D-87B3-CD87A67C7CE2Q36947246-FD93E2D0-B1C8-4EF9-8ED9-AD321732C5C3Q36984874-B4F2A379-A765-4F44-AC1F-1254B0449AEC
P50
name
Annekatrin Lukanova
@en
Annekatrin Lukanova
@nl
type
label
Annekatrin Lukanova
@en
Annekatrin Lukanova
@nl
prefLabel
Annekatrin Lukanova
@en
Annekatrin Lukanova
@nl